The Changing Face of Infantile Pompe Disease: A Report of Five Patients from the UAE
Objective: We aim to present our experience with infantile Pompe disease with focus on the impact of availability of treatment on awareness, diagnosis, and management of such patients.
Method: Case – review study of patients diagnosed with infantile Pompe disease and literature search.
Results: We identified five cases of infantile Pompe disease. The first was diagnosed by muscle biopsy; all others were diagnosed by enzyme assay on peripheral blood lymphocytes or dried blood spot. There was no determination of the CRIM status on these patients. Two have died at a much later age than the reported median age of death for untreated cases. One died very early at 2 months of age with severe cardiomyopathy and had received only one dose of enzyme replacement therapy (ERT). The remaining two surviving patients are siblings: the younger was diagnosed by prenatal ultrasound screening and started on ERT at 24 h of age; she is the youngest treated patient in our case series.
Conclusion: The natural history of infantile Pompe disease is changing, so are the challenges of managing these infants in the post- ERT era. Currently, increased awareness and early access to therapy provide the best outcomes and incur the least shift of burden from mortality to morbidity.
Disclosure: Authors have received travel support to attend scientific symposiums by Genzyme. WF has also received consulting fees for speaking in a scientific symposium by Genzyme.
- The Changing Face of Infantile Pompe Disease: A Report of Five Patients from the UAE
- Book Title
- JIMD Reports - Case and Research Reports, 2012/5
- pp 7-10
- Print ISBN
- Online ISBN
- Series Title
- JIMD Reports
- Series Volume
- Series ISSN
- Springer Berlin Heidelberg
- Copyright Holder
- SSIEM and Springer-Verlag Berlin Heidelberg
- Additional Links
- Industry Sectors
- eBook Packages
- Editor Affiliations
- ID1. Sektionen für Humangenetik und Klinische, Medizinische Universität Innsbruck
- ID2. , Biological Sciences, Michigan Technological University
- ID3. , Department of Biochemistry, University of Oxford
- ID4. Medical Center, Department of Pediatrics, Radboud University Nijmegen
- ID5. Heidelberg University Hospital, Center for Child and Adolescent Medicine
- Author Affiliations
- 1. Division of Pediatric Neurology, Pediatric Institute, Sheikh Khalifa Medical City, 51900, Abu Dhabi, UAE
To view the rest of this content please follow the download PDF link above.